Pancreatic Cancer Research

ResearcherInstitute for Glyco-core ResearchActive in the last 2 years

Yutaka Kondo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3746-3191; OpenAlex author ID A5073048235. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
37
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer. Last author DOI 10.1038/s41416-025-03299-5↗
  2. CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer. Co-author DOI 10.1159/000527342↗
  3. Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer. Last author DOI 10.1158/0008-5472.can-20-3021↗
  4. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-020-08990-w↗
  5. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer. Last author DOI 10.1371/journal.pone.0233782↗
  6. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/onc.2014.101↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keiko Shinjo · 6 shared papers, 2015–2026 · strength 0.70
  2. Reo Maruyama · 1 shared paper, 2026 · strength 0.25
  3. Shinji Mii · 1 shared paper, 2026 · strength 0.25
  4. Xingxing Wang · 1 shared paper, 2026 · strength 0.25
  5. Atsushi Enomoto · 1 shared paper, 2026 · strength 0.25
  6. Satoru Takahashi · 2 shared papers, 2020–2021 · strength 0.19
  7. Kaori Hamamoto · 1 shared paper, 2022 · strength 0.12
  8. Yuko Fujimoto · 1 shared paper, 2022 · strength 0.12
  9. Shogo Amano · 1 shared paper, 2022 · strength 0.12
  10. Taro Takami · 1 shared paper, 2022 · strength 0.12
  11. Hiroaki Nagano · 1 shared paper, 2022 · strength 0.12
  12. Isao Sakaida · 1 shared paper, 2022 · strength 0.12
  13. Yutaka Suehiro · 1 shared paper, 2022 · strength 0.12
  14. Takahiro Yamasaki · 1 shared paper, 2022 · strength 0.12
  15. Hiroto Matsui · 1 shared paper, 2022 · strength 0.12
  16. Shigeyuki Suenaga · 1 shared paper, 2022 · strength 0.12
  17. Masaya Suenaga · 1 shared paper, 2021 · strength 0.11
  18. Mitsuro Kanda · 1 shared paper, 2021 · strength 0.11
  19. Fuminori Sonohara · 1 shared paper, 2021 · strength 0.11
  20. Masamichi Hayashi · 1 shared paper, 2021 · strength 0.11
  21. Suguru Yamada · 1 shared paper, 2021 · strength 0.11
  22. Yasuhiro Kodera · 1 shared paper, 2021 · strength 0.11
  23. Tsutomu Fujii · 1 shared paper, 2021 · strength 0.11
  24. Hiromi Kataoka · 1 shared paper, 2021 · strength 0.10
  25. Yoshihiko Tasaki · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.